Defeng Wang

1.5k total citations · 1 hit paper
21 papers, 1.0k citations indexed

About

Defeng Wang is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Defeng Wang has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 3 papers in Infectious Diseases and 3 papers in Organic Chemistry. Recurrent topics in Defeng Wang's work include Wnt/β-catenin signaling in development and cancer (3 papers), interferon and immune responses (2 papers) and HIV Research and Treatment (2 papers). Defeng Wang is often cited by papers focused on Wnt/β-catenin signaling in development and cancer (3 papers), interferon and immune responses (2 papers) and HIV Research and Treatment (2 papers). Defeng Wang collaborates with scholars based in China, Belgium and Hong Kong. Defeng Wang's co-authors include Lei Wang, Qiong Wu, Bo Zhang, Ben Li, You Zhou, Xinyong Liu, Erik De Clercq, Christophe Pannecouque, Zengjun Fang and Peng Zhan and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Molecules and Acta Biomaterialia.

In The Last Decade

Defeng Wang

18 papers receiving 1.0k citations

Hit Papers

m6A regulator-mediated methylation modification patterns ... 2020 2026 2022 2024 2020 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Defeng Wang China 11 709 370 245 206 107 21 1.0k
Jiadi Luo China 17 699 1.0× 320 0.9× 116 0.5× 165 0.8× 25 0.2× 43 928
Francisco Martínez-Jiménez Spain 12 740 1.0× 447 1.2× 208 0.8× 270 1.3× 29 0.3× 13 1.1k
Parunya Chaiyawat Thailand 17 457 0.6× 187 0.5× 125 0.5× 137 0.7× 97 0.9× 40 653
Fumiko Axelrod United States 9 895 1.3× 568 1.5× 97 0.4× 458 2.2× 37 0.3× 24 1.4k
Robert Kubiak Poland 18 553 0.8× 196 0.5× 67 0.3× 206 1.0× 70 0.7× 77 1.1k
Douglas Bootle Switzerland 13 718 1.0× 150 0.4× 304 1.2× 582 2.8× 86 0.8× 17 1.2k
Jian An China 17 1.1k 1.6× 299 0.8× 279 1.1× 413 2.0× 22 0.2× 37 1.5k
Hailing Lu China 19 603 0.9× 285 0.8× 136 0.6× 286 1.4× 16 0.1× 35 894

Countries citing papers authored by Defeng Wang

Since Specialization
Citations

This map shows the geographic impact of Defeng Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Defeng Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Defeng Wang more than expected).

Fields of papers citing papers by Defeng Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Defeng Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Defeng Wang. The network helps show where Defeng Wang may publish in the future.

Co-authorship network of co-authors of Defeng Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Defeng Wang. A scholar is included among the top collaborators of Defeng Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Defeng Wang. Defeng Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Tong, Yan Yang, Li Sun, et al.. (2025). Efficacy of Mesenchymal Stem Cells in the Treatment of Diabetic Foot Ulcers: A Meta-Analysis of Randomized Controlled Trials. The International Journal of Lower Extremity Wounds. 2173598525–2173598525.
2.
Liu, Qianqian, Rui Jiang, Chenxing Wang, et al.. (2024). An engineered cellular carrier delivers miR-138–5p to enhance mitophagy and protect hypoxic-injured neurons via the DNMT3A/Rhebl1 axis. Acta Biomaterialia. 186. 424–438. 10 indexed citations
3.
Wang, Yuzhong, et al.. (2024). Loxenatide Alleviates High Glucose-Induced Pancreatic β-Cell Senescence via Regulating the PERK/eIF2α Pathway. Hormone and Metabolic Research. 56(12). 890–899. 1 indexed citations
5.
Yang, Yan, Shuo Li, Mengru Liu, et al.. (2023). Efficacy of fecal microbiota transplantation in type 2 diabetes mellitus: a systematic review and meta-analysis. Endocrine. 84(1). 48–62. 18 indexed citations
6.
Wang, Yuzhong, et al.. (2023). Loxenatide attenuates ROS‐mediated vascular endothelial progenitor cell damage and mitochondrial dysfunction via SIRT3/Foxo3 signaling pathway. Journal of Biochemical and Molecular Toxicology. 37(11). e23452–e23452. 5 indexed citations
7.
Yao, Min, Jianjun Wang, Xiyu Chen, et al.. (2022). Oncogenic Wnt3a is a promising sensitive biomarker for monitoring hepatocarcinogenesis. Hepatobiliary & pancreatic diseases international. 22(3). 263–269. 3 indexed citations
8.
Yan, Ning, et al.. (2022). Synthesis and biological evaluation of thieno[3,2- c ]pyrazol-3-amine derivatives as potent glycogen synthase kinase 3β inhibitors for Alzheimer’s disease. Journal of Enzyme Inhibition and Medicinal Chemistry. 37(1). 1724–1736. 14 indexed citations
9.
Yao, Min, Yin Cai, Zhijun Wu, et al.. (2022). Effects of targeted-edited oncogenic insulin-like growth factor-1 receptor with specific-sgRNA on biological behaviors of HepG2 cells. World Journal of Clinical Cases. 10(28). 10017–10030.
10.
Zhang, Jian, Waleed A. Zalloum, Ruifang Jia, et al.. (2020). Discovery of novel “Dual-site” binding oseltamivir derivatives as potent influenza virus neuraminidase inhibitors. European Journal of Medicinal Chemistry. 191. 112147–112147. 10 indexed citations
11.
Zhang, Bo, Qiong Wu, Ben Li, et al.. (2020). m6A regulator-mediated methylation modification patterns and tumor microenvironment infiltration characterization in gastric cancer. Molecular Cancer. 19(1). 53–53. 717 indexed citations breakdown →
12.
Cao, Shuo, et al.. (2020). Tubulin Maytansine Site Binding Ligands and their Applications as MTAs and ADCs for Cancer Therapy. Current Medicinal Chemistry. 27(27). 4567–4576. 16 indexed citations
13.
Wang, Zhen, Li Sun, Shuang Liang, et al.. (2019). GPER stabilizes F-actin cytoskeleton and activates TAZ via PLCβ-PKC and Rho/ROCK-LIMK-Cofilin pathway. Biochemical and Biophysical Research Communications. 516(3). 976–982. 26 indexed citations
14.
Wang, Defeng, Wei Jiao, Guang Chen, et al.. (2017). Bioinformatics analyses of pathways and gene predictions in IL-1α and IL-1β knockout mice with spinal cord injury. Acta Histochemica. 119(7). 663–670. 5 indexed citations
15.
Sun, Li, et al.. (2016). Extracellular matrix protein ITGBL1 promotes ovarian cancer cell migration and adhesion through Wnt/PCP signaling and FAK/SRC pathway. Biomedicine & Pharmacotherapy. 81. 145–151. 33 indexed citations
17.
Xu, Jian, Ying Liu, Xudong Wang, et al.. (2015). Association between KIAA1199 overexpression and tumor invasion, TNM stage, and poor prognosis in colorectal cancer.. PubMed. 8(3). 2909–18. 30 indexed citations
18.
Kong, Ling, Zhongfang Liu, Shaopu Liu, & Defeng Wang. (2012). Interaction of vancomycin with DNA, and determination of DNA via resonance Rayleigh scattering and resonance nonlinear scattering. Analytical Methods. 4(12). 4346–4346. 7 indexed citations
19.
Xie, Fei, et al.. (2010). Novel Synthesis of 3-Arylated 5,6-Dimethoxybenzo[d]isothiazole 1,1- Dioxides. Letters in Organic Chemistry. 7(4). 332–334. 1 indexed citations
20.
Zhan, Peng, Xinyong Liu, Zhenyu Li, et al.. (2009). Novel 1,2,3-thiadiazole derivatives as HIV-1 NNRTIs with improved potency: Synthesis and preliminary SAR studies. Bioorganic & Medicinal Chemistry. 17(16). 5920–5927. 78 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026